Want to see SE:APOTEA full AI Analyst Report?
APOTEA Stock Chart & Stats
kr75.30
-kr0.22(-0.29%)
At close: 4:00 PM EST
kr75.30
-kr0.22(-0.29%)
Day’s Range― - ―
52-Week Rangekr54.42 - kr94.50
Previous CloseN/A
Volume107.34K
Average Volume (3M)229.69K
Market Cap
kr9.45B
Enterprise Valuekr7.92B
Total Cash (Recent Filing)kr103.50M
Total Debt (Recent Filing)kr279.30M
Price to Earnings (P/E)38.5
Beta0.43
Next Earnings
Nov 05, 2026EPS Estimate
0.71Next Dividend Ex-DateN/A
Dividend Yield0.66%
Share Statistics
EPS (TTM)2.36
Shares Outstanding104,070,970
10 Day Avg. Volume248,850
30 Day Avg. Volume229,694
Financial Highlights & Ratios
PEG Ratio7.96
Price to Book (P/B)11.37
Price to Sales (P/S)1.33
P/FCF Ratio81.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.81
Revenue Forecast (FY)kr8.07B
Bulls Say, Bears Say
Bulls Say
Revenue GrowthRevenue has continued to expand, with TTM revenue up approximately 2.7% and the reported revenue-growth measure at 9.35%. Continued top-line gains indicate ongoing customer demand and provide a foundation for scale benefits over the next several quarters.
Improved ProfitabilityProfitability has materially improved from earlier years, while gross margin remains around 25% and operating profitability near 4% of sales. This suggests better scale and cost control, strengthening the business model even though earnings margins remain modest.
Manageable LeverageDebt has declined relative to equity, with TTM leverage at roughly one-third of equity, while equity has grown alongside assets. This improving capital structure supports financial resilience and preserves more flexibility to fund operations or growth.
Bears Say
Weaker Cash ConversionAlthough free cash flow remains positive, its approximately 31.8% decline and coverage of only about 0.69 times TTM net income show weaker conversion into cash. This can constrain reinvestment flexibility and makes durable earnings quality more dependent on improvement.
Thin MarginsOperating and net margins remain relatively thin at about 4% and 3.2% of sales, and have not meaningfully expanded since 2024. Limited margin protection leaves less room to absorb demand or pricing pressure and restricts operating leverage.
Weak EPS GrowthThe reported EPS growth rate of negative 91.93% indicates sharply weaker per-share earnings momentum, despite the improvement described in overall profitability. This signals that earnings progression remains fragile and could limit the company’s ability to compound shareholder returns.
Apotea AB News
APOTEA FAQ
What was Apotea AB’s price range in the past 12 months?
Apotea AB lowest stock price was kr54.42 and its highest was kr94.50 in the past 12 months.
What is Apotea AB’s market cap?
Apotea AB’s market cap is kr9.45B.
When is Apotea AB’s upcoming earnings report date?
Apotea AB’s upcoming earnings report date is Nov 05, 2026 which is in 11 days.
How were Apotea AB’s earnings last quarter?
Apotea AB released its earnings results on Jul 17, 2026. The company reported kr0.77 earnings per share for the quarter, beating the consensus estimate of kr0.71 by kr0.06.
Is Apotea AB overvalued?
According to Wall Street analysts Apotea AB’s price is currently Overvalued.
Does Apotea AB pay dividends?
Apotea AB pays a Notavailable dividend of kr0.6 which represents an annual dividend yield of 0.66%. See more information on Apotea AB dividends here
What is Apotea AB’s EPS estimate?
Apotea AB’s EPS estimate is 0.71.
How many shares outstanding does Apotea AB have?
Apotea AB has 104,070,970 shares outstanding.
What happened to Apotea AB’s price movement after its last earnings report?
Apotea AB reported an EPS of kr0.77 in its last earnings report, beating expectations of kr0.71. Following the earnings report the stock price went up 7.87%.
Which hedge fund is a major shareholder of Apotea AB?
Currently, no hedge funds are holding shares in SE:APOTEA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Apotea AB
Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and drink, mouth and teeth, premium, trip, sex and lust, stop smoking, makeup, sun protection, wounds and injuries, sleep and sleep problems, training, weight control, vitamins and minerals, charity, and eyes and ears. In addition, the company offers services comprising leasing, leasing of personnel to related companies. and market contributions. The company was founded in 2011 and is headquartered in Stockholm, Sweden.